...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Reports of Exempt Distribution
Reply New Message
Back To Forum List View
Reports of Exempt Distribution
1
KOO-KOO2
Feb 04, 2023 09:01AM
Re: Reports of Exempt Distribution
1
Temsamany
Feb 06, 2023 11:59AM
Re: Reports of Exempt Distribution
1
KOO-KOO2
Feb 06, 2023 12:53PM
Re: Reports of Exempt Distribution
2
narmac
Feb 09, 2023 07:23AM
Re: Reports of Exempt Distribution
5
KOO-KOO2
Feb 09, 2023 08:01AM
Re: Reports of Exempt Distribution
3
narmac
Feb 09, 2023 08:30AM
Re: Reports of Exempt Distribution
3
KOO-KOO2
Feb 09, 2023 08:54AM
Re: Reports of Exempt Distribution
2
KayakerBC
Feb 09, 2023 10:08AM

Additional Reports of Exempt Distribution:

2023-01-31: 40,833  Common Shares @ 80 cents CAN = $32,707.00 out of USA

2023-02-10: 2, Convertable Notes CAN $133,362.00 each = $267,240.00 out of USA & Germany            with 150,000 share purchase warrants @ 80 cents CAN expire 2028-02-10

 

Koo

 

 

3 Recommendations
Re: Reports of Exempt Distribution
2
Toinv
Feb 22, 2023 09:43AM
Re: Reports of Exempt Distribution
1
jonzobot
Feb 23, 2023 02:56PM
Re: Reports of Exempt Distribution

KOO-KOO2
Feb 23, 2023 05:05PM
Re: Reports of Exempt Distribution
1
Toinv
Feb 24, 2023 10:39AM
Icon president Re: Reports of Exempt Distribution
2
Nextblockbuster
Feb 24, 2023 11:27AM
Re: Reports of Exempt Distribution

KOO-KOO2
Feb 24, 2023 12:05PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply